POLISCOPE
Back to feed
Part ofHealth →

The civic record

Read. Follow. Verify.

Senate Resolution to Designate May 2026 as PSP and CBD Awareness Month

Original title: SENATE RESOLUTION 752--EXPRESSING SUPPORT FOR THE DESIGNATION OF THE MONTH OF MAY 2026 AS "PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION AWARENESS MONTH"

Record date · May 21, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This resolution formally supports designating May 2026 as 'Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month.' It highlights the need for increased research, better diagnostic tools, and support for those living with these rare conditions.

Why it matters

The resolution serves as a formal federal recognition of two rare brain diseases, which may influence future research funding priorities and public health education efforts for the estimated 32,000 Americans currently diagnosed with these conditions.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Individuals diagnosed with PSP or CBD

The resolution recognizes their condition and supports efforts toward finding treatments and cures.

Directly affected

Family caregivers and loved ones

The resolution acknowledges the impact of these diseases on their lives and commends their efforts.

Directly affected

Healthcare professionals and researchers

The resolution commends their work and supports the goals of their research into these diseases.

Key Facts

  • The Senate supports designating May 2026 as 'Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month'.
  • Approximately 30,000 Americans are estimated to be living with progressive supranuclear palsy (PSP).
  • Approximately 2,000 Americans are estimated to be living with corticobasal degeneration (CBD).
  • PSP and CBD are described as rare, adult-onset, rapidly progressing neurodegenerative disorders.
Show all 9 facts
  • Most individuals with these conditions become dependent on care within 3 to 4 years of symptom onset.
  • The average life expectancy for those with these conditions is 7 to 8 years from symptom onset.
  • There are currently no disease-modifying treatments available for PSP or CBD.
  • The resolution supports increased research into diagnosis, prevention, treatments, and cures for both diseases.
  • The resolution commends the caregivers, researchers, and healthcare professionals working with affected individuals.

Frequently Asked Questions

What are PSP and CBD?
They are rare, rapidly progressing disorders that affect the brain and cause complex symptoms related to movement, balance, speech, swallowing, cognition, and vision.
Does this resolution provide funding for research?
No, this is a resolution expressing support for the awareness month and the goals of research; it does not explicitly allocate specific federal funds.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Rare Disease Awareness

The resolution highlights a specific legislative focus on rare, adult-onset neurodegenerative disorders that are frequently misdiagnosed.

Connected Entities

Committee on Health, Education, Labor, and Pensions, Richard Blumenthal
OrganizationCommittee on Health, Education, Labor, and Pensions“The Senate committee to which the resolution was referred.”Map →
PersonRichard Blumenthal“U.S. Senator who submitted the resolution.”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance20
    How much this matters to a regular citizen
  • Controversy0
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record